Axon is expanding beyond TASER devices and body cameras into AI-powered public safety software. Here's why AXON could benefit from the next phase of AI adoption.
Biotech and health care stocks are hitting new highs after promising Merck and Moderna cancer vaccine results. Here’s why the bull market could continue.
Druckenmiller is loading up on biotech. Eaton's earnings confirm the power grid boom. And WSM's new high says the American consumer is alive and thriving.